Saadet Inan, Ph.D. - Publications

2010 Pharmacology Temple University, Philadelphia, PA, United States 
Pharmacology, Neurobiology Biology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Eisenstein TK, Chen X, Inan S, Meissler JJ, Tallarida CS, Geller EB, Rawls SM, Cowan A, Adler MW. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management. Military Medicine. 185: 130-135. PMID 32074321 DOI: 10.1093/milmed/usz320  0.44
2019 Inan S, Huerta AT, Jensen LE, Dun NJ, Cowan A. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. European Journal of Pharmacology. 172702. PMID 31568781 DOI: 10.1016/j.ejphar.2019.172702  0.48
2019 Chen X, Cowan A, Inan S, Geller EB, Meissler JJ, Rawls SM, Tallarida RJ, Tallarida CS, Watson MN, Adler MW, Eisenstein TK. Opioid-Sparing Effects of Cannabinoids on Morphine Analgesia: Participation of CB1 and CB2 Receptors. British Journal of Pharmacology. PMID 31218677 DOI: 10.1111/bph.14769  0.44
2019 Inan S, Watson MN, Doura M, Tallarida CS, Meissler JJ, Chen X, Geller EB, Cowan A, Rawls SM, Eisenstein TK, Adler MW. Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats. British Journal of Anaesthesia. PMID 30916010 DOI: 10.1016/j.bja.2019.01.021  0.44
2018 Inan S, Eisenstein TK, Watson MN, Doura M, Meissler JJ, Tallarida CS, Chen X, Geller EB, Rawls SM, Cowan A, Adler MW. Co-Administration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 30249618 DOI: 10.1124/jpet.118.252890  0.44
2015 Qu H, Costache MC, Inan S, Cowan A, Devore D, Ducheyne P. Local, Controlled Delivery of Local Anesthetics In Vivo from Polymer - Xerogel Composites. Pharmaceutical Research. PMID 26555665 DOI: 10.1007/s11095-015-1822-z  0.48
2015 Cowan A, Kehner GB, Inan S. Targeting Itch with Ligands Selective for κ Opioid Receptors. Handbook of Experimental Pharmacology. 226: 291-314. PMID 25861786 DOI: 10.1007/978-3-662-44605-8_16  0.48
2013 Wei H, Inan S. Dual effects of neuroprotection and neurotoxicity by general anesthetics: role of intracellular calcium homeostasis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 47: 156-61. PMID 23721657 DOI: 10.1016/j.pnpbp.2013.05.009  0.48
2013 Zhao X, Yang Z, Liang G, Wu Z, Peng Y, Joseph DJ, Inan S, Wei H. Dual effects of isoflurane on proliferation, differentiation, and survival in human neuroprogenitor cells. Anesthesiology. 118: 537-49. PMID 23314167 DOI: 10.1097/ALN.0b013e3182833fae  0.48
2011 Inan S, Dun NJ, Cowan A. Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice. Peptides. 32: 286-92. PMID 21126550 DOI: 10.1016/j.peptides.2010.11.022  0.48
2010 Inan S, Wei H. The cytoprotective effects of dantrolene: a ryanodine receptor antagonist. Anesthesia and Analgesia. 111: 1400-10. PMID 20861418 DOI: 10.1213/ANE.0b013e3181f7181c  0.48
2009 Inan S, Dun NJ, Cowan A. Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence. European Journal of Pharmacology. 616: 141-6. PMID 19549515 DOI: 10.1016/j.ejphar.2009.06.026  0.48
2009 Inan S, Dun NJ, Cowan A. Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice. Neuroscience. 163: 23-33. PMID 19524022 DOI: 10.1016/j.neuroscience.2009.06.016  0.48
2007 Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology. 148: 5088-94. PMID 17627999 DOI: 10.1210/en.2007-0701  0.48
2006 Inan S, Cowan A. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacology, Biochemistry, and Behavior. 85: 39-43. PMID 16919318 DOI: 10.1016/j.pbb.2006.07.004  0.48
2005 Inan S, Cowan A. Reduced kappa-opioid activity in a rat model of cholestasis. European Journal of Pharmacology. 518: 182-6. PMID 16054619 DOI: 10.1016/j.ejphar.2005.06.025  0.48
2005 Rawls SM, Hewson JM, Inan S, Cowan A. Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in rats. Brain Research. 1049: 61-9. PMID 15936000 DOI: 10.1016/j.brainres.2005.04.074  0.48
2005 Zhang N, Inan S, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proceedings of the National Academy of Sciences of the United States of America. 102: 4536-41. PMID 15764707 DOI: 10.1073/pnas.0406030102  0.44
2005 Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. The Journal of Pharmacology and Experimental Therapeutics. 312: 220-30. PMID 15383632 DOI: 10.1124/jpet.104.073668  0.48
2004 Inan S, Cowan A. Kappa opioid agonists suppress chloroquine-induced scratching in mice. European Journal of Pharmacology. 502: 233-7. PMID 15476749 DOI: 10.1016/j.ejphar.2004.09.010  0.48
2004 Inan S, Tallarida RJ. Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric artery. European Journal of Pharmacology. 486: 61-5. PMID 14751409 DOI: 10.1016/j.ejphar.2003.12.010  0.48
Show low-probability matches.